ABVX · Abivax ADR
United States · RS rating 26 · As of 2026-11-03
| Price | 88.71 USD |
|---|---|
| 1-day change | +4.5% |
| RS rating (overall / 1M / 3M / 12M) | 26 / 48 / 21 / 41 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 34 / 12 / 31 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -141.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +39.0% |
| Market cap (USD) | $9.0B |